AstraZeneca PLC
BMV:AZNN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
BMV:AZNN
Watchlist
Price: 1 703.02 MXN 2.78% Market Closed
Market Cap: 5.3T MXN

Relative Value

The Relative Value of one AZNN stock under the Base Case scenario is hidden MXN. Compared to the current market price of 1 703.02 MXN, AstraZeneca PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AZNN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
29
Median 3Y
4.5
Median 5Y
4.6
Industry
2.6
Forward
0
vs History
68
vs Industry
13
Median 3Y
33.6
Median 5Y
34.7
Industry
21.4
Forward
0.2
vs History
68
vs Industry
23
Median 3Y
19.6
Median 5Y
21.3
Industry
16.4
vs History
47
vs Industry
16
Median 3Y
38.9
Median 5Y
32.4
Industry
22.8
vs History
19
vs Industry
12
Median 3Y
5.6
Median 5Y
5.5
Industry
2.2
vs History
88
vs Industry
5
Median 3Y
45.6
Median 5Y
47.4
Industry
2.9
Forward
0.4
vs History
92
vs Industry
3
Median 3Y
55.5
Median 5Y
57.8
Industry
5.5
vs History
93
vs Industry
2
Median 3Y
138.7
Median 5Y
156.1
Industry
13
Forward
1.1
vs History
93
vs Industry
2
Median 3Y
222.7
Median 5Y
257.9
Industry
16.5
Forward
1.2
vs History
93
vs Industry
2
Median 3Y
200.5
Median 5Y
214.5
Industry
15.6
vs History
92
vs Industry
1
Median 3Y
302
Median 5Y
338.6
Industry
18.7
vs History
69
vs Industry
3
Median 3Y
29
Median 5Y
29.9
Industry
1.9

Multiples Across Competitors

AZNN Competitors Multiples
AstraZeneca PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
AstraZeneca PLC
BMV:AZNN
220.6B MXN 5.1 31.7 108.8 159.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.5 56.4 37.8 40.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497.7B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
269.3B CHF 4.4 28.6 12.2 14.2
US
Merck & Co Inc
NYSE:MRK
269.9B USD 4.2 14.2 10 11.9
CH
Novartis AG
SIX:NOVN
218B CHF 4.9 19 12 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
FR
Sanofi SA
PAR:SAN
100.7B EUR 1.5 7.3 6.7 6.7
P/E Multiple
Earnings Growth PEG
UK
AstraZeneca PLC
BMV:AZNN
Average P/E: 23
31.7
37%
0.9
US
Eli Lilly and Co
NYSE:LLY
56.4
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.6
29%
1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
FR
Sanofi SA
PAR:SAN
7.3
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
AstraZeneca PLC
BMV:AZNN
Average EV/EBITDA: 400.6
108.8
10%
10.9
US
Eli Lilly and Co
NYSE:LLY
37.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
US
Merck & Co Inc
NYSE:MRK
10
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
FR
Sanofi SA
PAR:SAN
6.7
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
AstraZeneca PLC
BMV:AZNN
Average EV/EBIT: 1 713
159.2
23%
6.9
US
Eli Lilly and Co
NYSE:LLY
40.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
US
Merck & Co Inc
NYSE:MRK
11.9
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5
FR
Sanofi SA
PAR:SAN
6.7
15%
0.4